<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study examines the occurrence, subtype and possible significance of haemopoietic inhibitory T cells (HIT cells) in patients with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (n = 21), <z:hpo ids='HP_0011009'>acute</z:hpo> myeloblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (n = 8) and in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (n = 13) using an autostimulary CFU-GM stem cell assay </plain></SENT>
<SENT sid="1" pm="."><plain>HIT cells were detected when colony numbers increased by 30% or more following T-lymphocyte subpopulation ablation </plain></SENT>
<SENT sid="2" pm="."><plain>HIT cells occurred in 28% of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, were always CD8-positive and never occurred in the <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="3" pm="."><plain>Sequential studies in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with HIT cells and treated with low dose Ara-C showed no correlation between occurrence of these cells and clinical outcome </plain></SENT>
<SENT sid="4" pm="."><plain>HIT cells appear to be a clinically irrelevant manifestation of the cell dysfunction associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>